O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.91B
AUM Growth
-$1.07B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$139M
2
+$132M
3
+$110M
4
PFE icon
Pfizer
PFE
+$98.3M
5
GILD icon
Gilead Sciences
GILD
+$85.6M

Top Sells

1
+$372M
2
+$99.8M
3
+$98.1M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$93.8M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$68M

Sector Composition

1 Healthcare 97.58%
2 Financials 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$14.5M 0.24%
+1,477,320
77
$14.3M 0.24%
6,767,584
78
$13.4M 0.22%
114,621
79
$13.1M 0.22%
254,000
-260,000
80
$11.5M 0.19%
1,305,034
+690,166
81
$10.9M 0.18%
36,216
82
$10.6M 0.18%
3,670,955
83
$10.5M 0.18%
46,090
+1,090
84
$10.3M 0.17%
55,265
+2,373
85
$10M 0.17%
113,200
86
$9.85M 0.17%
127,200
87
$8.76M 0.15%
9,520,600
+4,520,600
88
$8.67M 0.15%
267,700
+240,900
89
$8.4M 0.14%
17,200
-192,100
90
$7.85M 0.13%
53,869
-29,064
91
$7.83M 0.13%
+16,467
92
$6.87M 0.12%
2,525,654
+1,174,999
93
$6.57M 0.11%
+300,000
94
$6.31M 0.11%
+537,420
95
$6.28M 0.11%
2,605,531
96
$6.25M 0.11%
86,462
-9,507
97
$6.17M 0.1%
9,207,012
98
$5.89M 0.1%
1,471,853
99
$5.78M 0.1%
+92,700
100
$5.6M 0.09%
133,400
+23,400
2 3
4
5 6